tirzepatide
Get the evidence digestComparisons
ComparisonsTirzepatide alternatives: how the real options compareSemaglutide, retatrutide, orforglipron, and lifestyle programs, compared against tirzepatide's SURMOUNT and SURPASS data on weight loss and side effects.Read guide →ComparisonsTirzepatide vs Mounjaro vs Zepbound: what actually differsMounjaro and Zepbound are the same FDA drug, tirzepatide, at different doses for different labels. Here's the real trial data, cost, and how compounded fits in.Read guide →ComparisonsTirzepatide vs Ozempic: comparing tirzepatide and semaglutideTirzepatide vs semaglutide (Ozempic): SURPASS/SURMOUNT vs STEP trial data, weight loss %, dosing, side effects, and cost compared head-to-head.Read guide →ComparisonsTirzepatide vs retatrutide: how the two GLP-1 drugs compareTirzepatide has FDA approval and phase 3 data showing up to 20.9% weight loss. Retatrutide is still in trials, with phase 2 results near 24%. Full comparison.Read guide →ComparisonsTirzepatide vs semaglutide: what the trial data showsHead-to-head trial data: tirzepatide averaged 15-21% weight loss vs semaglutide's 15%. Compare SURMOUNT, STEP, dosing, side effects, and cost.Read guide →ComparisonsTirzepatide vs Wegovy: how tirzepatide stacks upWegovy averaged 15.2% weight loss at 68 weeks; tirzepatide hit 20.9% at 72 weeks (SURMOUNT-1). Full head-to-head on dosing, cost, and side effects.Read guide →